Savient Pharmaceuticals
| Industry | Pharmaceuticals |
|---|---|
| Defunct | 2013 |
| Headquarters | , United States |
| Products | Pegloticase, oxandrolone |
| Website | http://www.savientpharma.com/ |
Savient Pharmaceuticals was a New Jersey–based biopharmaceutical company. Its lead product, pegloticase, was a biologic drug for treatment resistant chronic gout, which it marketed beginning in 2011. It also marketed oxandrolone beginning in 1995.